Marijuana Enforcement Division 2026 Regulatory Agenda Report

Marijuana Enforcement Division 2026 Regulatory Agenda Report

The Colorado Department of Revenue (CDOR) submits the following 2026 Departmental Regulatory Agenda Report (Report) in fulfillment of the statutory requirements set forth in §2-7-202(6), 2-7-203, and 24-4-103.3(4), C.R.S. Pursuant to state law, annually on November 1 executive-branch agencies must file the Report in order to provide results of the past year's rulemaking activity. Pursuant to §2-7- 202(6), C.R.S., the Report must contain:

  • (f) Commencing with departmental regulatory agendas submitted on and after November 1, 2013, a list and brief summary of all permanent and temporary rules actually adopted since the previous departmental regulatory agenda was filed. Pursuant to §24-4-103.3(4), C.R.S., the Report must contain:
  • (4) Each principal department shall include a report on the results of its mandatory review of rules as part of its departmental regulatory agenda that it submits to the staff of the legislative council for distribution to the applicable committee of reference of the general assembly as outlined in section 2-7-203, C.R.S.

The Agenda is to be filed with Legislative Council Staff for distribution to committee(s) of reference, posted on CDOR’s website, and submitted to the State Library, the Colorado Department of Regulatory Agencies, and the Secretary of State for publication in the Colorado Register. CDOR must also present its Report as part of its “SMART Act” presentation pursuant to §2-7-203(2)(a), C.R.S. CDOR works with several boards and commissions that promulgate rules; for ease of use for the consumer, those rules are included in CDOR's Report. The Report covers Calendar Year 2026 (CY26). Rules that will be completed after November 1, 2026, are marked as "ongoing" or "in progress".

Results of Activity Included in Last Regulatory Agenda (2026)
Rule Number (ex: 1 CCR 201-1, Rule #101)Rule Title (or Brief Description)New rule, revision, or repeal?Statutory or other basis for adoption of rulePurpose (For the change, ex: legislation)StakeholdersStatusAdoption Date (if applicable)
1 CCR 212-3 Rule 2-100 SeriesFeesRevision44-10-103, 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(b), 44-10-203(2)(h), 44-10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303(2)(b), 44-10-310(7), 44-10-313, 44-10-401, 44-10-801, 44-10-802, 44-10-803, 44-10-1201, 44-10-1202, C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(II).Statutory mandate to evaluate fees annually to reflect direct and indirect costs of administering the program. COMMENTS: 2.4% inflationary increase; other fee adjustmentsMED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 2-145 Social Equity FeesFeesRevision44-10-103, 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(b), 44-10-203(2)(h), 44-10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303(2)(b), 44-10-308(5); 44-10-310(7), 44-10-313, 44-10-401, 44-10-801, 44-10-802, 44-10-803, 44-10-1201, 44-10-1202, C.R.SStatutory mandate to evaluate fees annually to reflect direct and indirect costs of administering the program. Additionally, the State Licensing Authority is expressly permitted by statute to adopt reduced fees for Social Equity Licensees. COMMENTS: Fee adjustmentsMED Stakeholder ListAdopted09/10/2026
Unplanned Rulemaking - Not Part of Regulatory Agenda or Mandatory Rules Review
Rule Number (ex: 1 CCR 201-1, Rule #101)Rule Title (or Brief Description)New rule, revision, or repeal?Statutory or other basis for adoption of rulePurposeStakeholdersStatusAdoption Date (if applicable)
1 CCR 212-3 Rule 1-115DefinitionsRevision44-10-202(1)(c), 44-10-202(1)(j), and 44-10-103, C.R.S.Clarified, updated, or corrected the following definitions: Beneficial Owner, Commercially Reasonable Royalty, Harvested Marijuana, Microbial Control Step, Production Batch, Retail Marijuana Concentrate, Retail Marijuana Products Manufacturer, Retail Marijuana Store, Retail Marijuana Testing Facility, Sample Increment and Test BatchMED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 2-110(A)Requests for a Finding of Suitability, Owner License and Temporary Appointees – Initial Application and Renewal Fees.Repeal44-10-103, 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(b), 44-10-203(2)(h), 44-10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303(2)(b), 44-10-310(7), 44-10-313, 44-10-401, 44-10-801, 44-10-802, 44-10-803, 44-10-1201, 44-10-1202, C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(II).Finding of Suitability and License fees repealed and incorporated into a new rule and single payment.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 2-110(A)(1.5)Requests for a Finding of Suitability, Owner License and Temporary Appointees – Initial Application and Renewal Fees.New44-10-103, 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(b), 44-10-203(2)(h), 44-10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303(2)(b), 44-10-310(7), 44-10-313, 44-10-401, 44-10-801, 44-10-802, 44-10-803, 44-10-1201, 44-10-1202, C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(II).New rule reflecting the combined Finding of Suitability and license fees into a single payment. The new fee includes the 2.4% inflationary fee increase.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 2-110(B)(1)Requests for a Finding of Suitability, Owner License and Temporary Appointees – Initial Application and Renewal Fees.Repeal44-10-103, 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(b), 44-10-203(2)(h), 44-10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303(2)(b), 44-10-310(7), 44-10-313, 44-10-401, 44-10-801, 44-10-802, 44-10-803, 44-10-1201, 44-10-1202, C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(II).Owner and Owner Entity license fees repealed and incorporated into a new rule and single payment.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 2-110(B)(1) 2Requests for a Finding of Suitability, Owner License and Temporary Appointees – Initial Application and Renewal Fees.New44-10-103, 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(b), 44-10-203(2)(h), 44-10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303(2)(b), 44-10-310(7), 44-10-313, 44-10-401, 44-10-801, 44-10-802, 44-10-803, 44-10-1201, 44-10-1202, C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(II).New rule reflecting the combined yearly payments into a single license payment and the 2.4% inflationary fee increase.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 2-110(B)(2)Requests for a Finding of Suitability, Owner License and Temporary Appointees – Initial Application and Renewal Fees.Repeal44-10-103, 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(b), 44-10-203(2)(h), 44-10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303(2)(b), 44-10-310(7), 44-10-313, 44-10-401, 44-10-801, 44-10-802, 44-10-803, 44-10-1201, 44-10-1202, C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(II).Finding of Suitability and License fees repealed and incorporated into a new rule and single payment.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 2-110(C)(1)Requests for a Finding of Suitability, Owner License and Temporary Appointees – Initial Application and Renewal Fees.New44-10-103, 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(b), 44-10-203(2)(h), 44-10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303(2)(b), 44-10-310(7), 44-10-313, 44-10-401, 44-10-801, 44-10-802, 44-10-803, 44-10-1201, 44-10-1202, C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(II).New Temporary Appointee Registration fee and 2.4% inflationary fee increase. Rule was revised to clarify fee is required for each association of court appointmentMED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 2-120(B)(1)Permit FeesRevision44-10-103, 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(b), 44-10-203(2)(h), 44-10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303(2)(b), 44-10-310(7), 44-10-313, 44-10-401, 44-10-801, 44-10-802, 44-10-803, 44-10-1201, 44-10-1202, C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(II).The Delivery Permit fee was reduced to better align with the direct and indirect cost to process the applications / permits after Division analysis.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 2-140(B) & 1 CCR 212-3 Rule 2-140(B)(1)Other Application FeesNew44-10-103, 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(b), 44-10-203(2)(h), 44-10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303(2)(b), 44-10-310(7), 44-10-313, 44-10-401, 44-10-801, 44-10-802, 44-10-803, 44-10-1201, 44-10-1202, C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(II).New late fee required for failure to make 2nd year license fee payment. The late fee has been added to help offset the direct and indirect costs associated with the work required to collect the second payment due by the Division.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 2-145(B)(1)(a)Social Equity FeesRevision44-10-103, 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(b), 44-10-203(2)(h), 44-10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303(2)(b), 44-10-308(5); 44-10-310(7), 44-10-313, 44-10-401, 44-10-801, 44-10-802, 44-10-803, 44-10-1201, 44-10-1202, C.R.S.Finding of Suitability and License fees revised and incorporated into a single two-year payment.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 2-145(B)(1)(b)(1)Social Equity FeesRepeal44-10-103, 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(b), 44-10-203(2)(h), 44-10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303(2)(b), 44-10-308(5); 44-10-310(7), 44-10-313, 44-10-401, 44-10-801, 44-10-802, 44-10-803, 44-10-1201, 44-10-1202, C.R.S.Finding of Suitability and License fees repealed.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 2-145(B)(1)(b)Social Equity FeesRepeal44-10-103, 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(b), 44-10-203(2)(h), 44-10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303(2)(b), 44-10-308(5); 44-10-310(7), 44-10-313, 44-10-401, 44-10-801, 44-10-802, 44-10-803, 44-10-1201, 44-10-1202, C.R.S.License fees repealed and combined with the Finding of Suitability fees.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 2-145(B)(1)(c)Social Equity FeesRepeal44-10-103, 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(b), 44-10-203(2)(h), 44-10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303(2)(b), 44-10-308(5); 44-10-310(7), 44-10-313, 44-10-401, 44-10-801, 44-10-802, 44-10-803, 44-10-1201, 44-10-1202, C.R.S.License fees repealed and combined with the Finding of Suitability fees.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 2-145(B)(2)Social Equity FeesRevision44-10-103, 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(b), 44-10-203(2)(h), 44-10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303(2)(b), 44-10-308(5); 44-10-310(7), 44-10-313, 44-10-401, 44-10-801, 44-10-802, 44-10-803, 44-10-1201, 44-10-1202, C.R.S.Rule was revised to reflect a single payment for the two-year license fee.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 2-145(B)(2)(a)Social Equity FeesRepeal44-10-103, 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(b), 44-10-203(2)(h), 44-10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303(2)(b), 44-10-308(5); 44-10-310(7), 44-10-313, 44-10-401, 44-10-801, 44-10-802, 44-10-803, 44-10-1201, 44-10-1202, C.R.S.License fees repealed and combined with the Finding of Suitability fees.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 2-145(E)(1)Social Equity FeesRevision44-10-103, 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(b), 44-10-203(2)(h), 44-10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303(2)(b), 44-10-308(5); 44-10-310(7), 44-10-313, 44-10-401, 44-10-801, 44-10-802, 44-10-803, 44-10-1201, 44-10-1202, C.R.S.The Delivery Permit fee was reduced to better align with the direct and indirect cost to process the applications / permits after Division analysis.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 2-265(E)(1)(a)Owner and Employee License: License Requirements, Applications, Qualifications, and PrivilegesRevision44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(l), 44-10-203(2)(b)-(c), 44-10-203(2)(e), 44-10-203(2)(t)-(u), 44-10-203(2)(w), 44-10-307, 44-10-308(2), 44-10-313(6), 44-10-401(2)(c), 44-10-901(1), 24-76.5-101 et seq., C.R.S.Rule was revised to remove the requirement that conditional employee license applications be submitted in person at the Division.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 2-275(A)(1)(e)Temporary Appointee Registrations for Court AppointeesNew44-10-202(1)(b)-(c), 44-10-203(1)(k), 44-10-203(2)(q), 44-10-203(2)(t), 11-10-310, 44-10-401(3)(a)-(d), C.R.S.A new rule was added to reference the fee required by Rule 2-110(C) to the application requirements.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 2-275(A)(4)Temporary Appointee Registrations for Court AppointeesRevision44-10-202(1)(b)-(c), 44-10-203(1)(k), 44-10-203(2)(q), 44-10-203(2)(t), 11-10-310, 44-10-401(3)(a)-(d), C.R.S.Rule was revised for clarity regarding the timing of application and payment of fees.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 3-110(E)Regulated Marijuana Businesses: General RestrictionsNew44-10-202(1)(c), 44-10-203(1)(k), 44-10-203(2)(g), 44-10-203(2)(h), 44-10-401(2), 44-10-701(1)(a), 44-10-701(3)(d), and 44-10-701(3)(f), C.R.S.A new rule expressly prohibiting Regulated Marijuana Businesses from working with unlicensed operators. COMMENTS: The rule was created to expressly state the longstanding restriction prohibiting licensees from subcontracting, subleasing, or subletting with an unlicensed individual or entity. The rule is intended to ensure license privileges are only exercised by licensed parties.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 3-205(D)Limited Access AreasRevision44-10-103(14), 44-10-103(26), 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(k), 44-10-203(1)(l), 44-10-203(2)(h), 44-10-203(2)(p), and 44-10-203(2)(t), C.R.S.Rule was revised to clarify and align with the areas of the licensed premises that must be covered by video surveillance. Additionally, the Division identified opportunities in the language to clarify and improve the administration of the rule.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 3-225(C)(1)(e), 1 CCR 212-3 Rule 3-225(C)(2) & 1 CCR 212-3 Rule 3-225(C)(4)Video SurveillanceRevision44-10-203(2)(h), 44-10-203(1)(k), 44-10-203(2)(e), 44-10-313(14), and 44-10-1001, C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VI).Rules revisions were made throughout the rule to provide clarity and consistent language.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 3-605(H)(3)(i)Transport: All Regulated Marijuana BusinessesNew44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(h), 44-10-203(2)(n), 44-10-203(3)(c), 44-10-313(5)(b), 44-10-505, and 44-10-605 C.R.S.New rule was added to clarify that a testing facility will verify the number and weight or units of samples submitted for testing. COMMENTS: The rule is intended to give line of sight to the testing facility to source package information to make the determination regarding test batch size.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 3-805(D)(3)Regulated Marijuana Businesses: Inventory Tracking SystemRevision44-10-201(1), 44-10-202(1)(a), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(h), 44-10-501(1)(b), 44-10-502(2), 44-10-503(1)(b), 44-10-505(3), 44-10-601(1)(d), 44-10-602(3), 44-10-603(1)(b), 44-10-605(3), and 44-10-610(3)(a), C.R.S.Rule was revised to add "unless the system specifically permits reuse of the tag" for clarity and improved compliance.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 3-805(E)(6)Regulated Marijuana Businesses: Inventory Tracking SystemNew44-10-201(1), 44-10-202(1)(a), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(h), 44-10-501(1)(b), 44-10-502(2), 44-10-503(1)(b), 44-10-505(3), 44-10-601(1)(d), 44-10-602(3), 44-10-603(1)(b), 44-10-605(3), and 44-10-610(3)(a), C.R.S.A new rule was added providing guidance on when a Production Batch must be created in the Inventory Tracking System for clarity and improved compliance.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 3-905(B)(19)Business Records RequiredRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-301, and 44-10-1001(1), (3), and (4), C.R.S.Rules revisions were made throughout the rule to provide clarity.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 3-910(A)Reporting and Transmittal of TaxesRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), and 44-10-203(2)(j), C.R.S.Revised sales and use tax filing and remittance language for clarity.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 3-910(B.5) and 1 CCR 212-3 Rule 3-910(B.6)Reporting and Transmittal of TaxesNew44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), and 44-10-203(2)(j), C.R.S.New rule adding a requirement for accurate collection, accounting, and payment of excise taxes and requirement to report invoice/contract price discrepancies to the Inventory Tracking System within 30 days.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 3-910(C)Reporting and Transmittal of TaxesRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), and 44-10-203(2)(j), C.R.S.Rules revisions were made throughout the rule to provide clarity.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 3-1015(B)(3)(a)(ii), 1 CCR 212-3 Rule 3-1015(B)(4)(a)(i), 1 CCR 212-3 Rule 3-1015(B)(4)(b)(ii), and 1 CCR 212-3 Rule 3-1015(B)(5)(e)(i)Additional Labeling Requirements Prior to Transfer to a Patient or ConsumerNew44-10-202(1)(a), 44-10-202(1)(c), 44-10-202(6), 44-10-203(2)(d)(IV)(A)-(C), 44-10-203(2)(f), 44-10-203(2)(w), 44-10-203(1)(a), 44-10-601(2)(a), 44-10-603(4)(a), and 44-10-603(8), C.R.S.New rule adding requirements for any Cannabinoid that makes up 10% or more be included on the label.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 3-1015(B)(4)(b)Additional Labeling Requirements Prior to Transfer to a Patient or ConsumerRevision44-10-202(1)(a), 44-10-202(1)(c), 44-10-202(6), 44-10-203(2)(d)(IV)(A)-(C), 44-10-203(2)(f), 44-10-203(2)(w), 44-10-203(1)(a), 44-10-601(2)(a), 44-10-603(4)(a), and 44-10-603(8), C.R.S.Rule was revised to clarify transdermal potency statements must use milligrams per serving.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 3-1025(B)(2)(b)Packaging and Labeling: Minimum Requirements for Test Batch Transfers to a Regulated Marijuana Testing FacilityRevision44-10-202(1)(a), 44-10-202(1)(c), 44-10-202(6), 44-10-203(2)(f), 44-10-203(1)(k), 44-10-203(3)(a)-(b), C.R.S.Rule was revised for clarity by adding "or the license number of the Regulated Marijuana Cultivation Facility where the Physical Separation-Based Regulated Marijuana Concentrate was produced, if applicable".MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 3-1025(C)(2)(d)Packaging and Labeling: Minimum Requirements for Test Batch Transfers to a Regulated Marijuana Testing FacilityRevision44-10-202(1)(a), 44-10-202(1)(c), 44-10-202(6), 44-10-203(2)(f), 44-10-203(1)(k), 44-10-203(3)(a)-(b), C.R.S.Rule revision for clarity and compliance by adding "as required by Rule 3-1015(B).MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 4-205(F)(1)Regulated Marijuana Testing Program: Mandatory TestingNew44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1)(b), 44-10-504(2), 44-10-601(4), 44-10-602(4), 44-10-603(6), 44-10-604(1)(b), and 44-10-604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII).New rule clarifying who is financially responsible for sampling and testing if required by the Division.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 4-210(A)(2)(b) and 1 CCR 212-3 Rule 4-210(E)(2)Regulated Marijuana Testing Program: Potency TestingRevision44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1)(b), 44-10-504(2), 44-10-601(4), 44-10-602(4), 44-10-603(6), 44-10-604(1)(b), and 44-10-604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII).Rule was revised to ensure potency reporting for Regulated Marijuana Products to include the number of mgs contained within each of the four tested servings.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 4-210(A)(2)(c)Regulated Marijuana Testing Program: Potency TestingNew44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1)(b), 44-10-504(2), 44-10-601(4), 44-10-602(4), 44-10-603(6), 44-10-604(1)(b), and 44-10-604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII).New rule for potency reporting requirements for Topicals.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 4-210(E)(4)(a)(ii)Regulated Marijuana Testing Program: Potency TestingNew44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1)(b), 44-10-504(2), 44-10-601(4), 44-10-602(4), 44-10-603(6), 44-10-604(1)(b), and 44-10-604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII).New rule adding requirements for any Cannabinoid that makes up 10% or more be included in the testing process.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 4-210(E)(4)(b)Regulated Marijuana Testing Program: Potency TestingRepeal44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1)(b), 44-10-504(2), 44-10-601(4), 44-10-602(4), 44-10-603(6), 44-10-604(1)(b), and 44-10-604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII).Rule was repealed and replaced with 4-210(E)(4.5)MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 4-210(E)(4)(c)Regulated Marijuana Testing Program: Potency TestingRepeal44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1)(b), 44-10-504(2), 44-10-601(4), 44-10-602(4), 44-10-603(6), 44-10-604(1)(b), and 44-10-604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII).Rule was repealed and replaced with 4-210(E)(4.5)MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 4-210(E)(4.5)Regulated Marijuana Testing Program: Potency TestingNew44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1)(b), 44-10-504(2), 44-10-601(4), 44-10-602(4), 44-10-603(6), 44-10-604(1)(b), and 44-10-604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII).New rule consolidating Rule 4-210(E)(4)(b) and (c) regarding Edible Retail Marijuana Product potency failure requirements for clarity.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 4-210(E)(5)(c)Regulated Marijuana Testing Program: Potency TestingNew44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1)(b), 44-10-504(2), 44-10-601(4), 44-10-602(4), 44-10-603(6), 44-10-604(1)(b), and 44-10-604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII).New rule adding verification that package net contents contain the number of servings for clarity and improved compliance.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 4-215(E)(1) and 1 CCR 212-3 Rule 4-215(G)Regulated Marijuana Testing Program: Contaminant TestingRevision44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1)(b), 44-10-504(2), 44-10-601(4), 44-10-602(4), 44-10-603(6), 44-10-604(1)(b), and 44-10-604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII).Rule was revised to remove the microbiological contaminant list from the end of the Rule.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 4-220(A)Regulated Marijuana Testing Program: Research & Development TestingRevision44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1)(b), 44-10-504(2), 44-10-601(4), 44-10-602(4), 44-10-603(6), 44-10-604(1)(b), and 44-10-604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII).Rule was revised to clarified Research & Development testing and prohibited use of R&D testing for pesticides for Regulated Marijuana Concentrate.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 4-225(F)Regulated Marijuana Testing Program: Sampling ProceduresRevision44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1)(b), 44-10-504(2), 44-10-601(4), 44-10-602(4), 44-10-603(6), 44-10-604(1)(b), and 44-10-604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII).Rule was revised and clarified regarding minimum Sample Increment requirements.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 4-230(B)(1)Regulated Marijuana Testing Program: Reduced Testing Allowance ProceduresRevision44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1)(b), 44-10-504(2), 44-10-601(4), 44-10-602(4), 44-10-603(6), 44-10-604(1)(b), and 44-10-604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII).Rule was revised to add "used to create a Production Batch" and "for each/that category or Regulated Marijuana" for clarity.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 4-230(G) and 1 CCR 212-3 Rule 4-230(J)Regulated Marijuana Testing Program: Reduced Testing Allowance ProceduresRevision44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1)(b), 44-10-504(2), 44-10-601(4), 44-10-602(4), 44-10-603(6), 44-10-604(1)(b), and 44-10-604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII).Revised ongoing Reduced Testing Allowance testing frequencies to 30-days from the previous 90 day requirement.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 4-230(M)(2.5)Regulated Marijuana Testing Program: Reduced Testing Allowance ProceduresRevision44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1)(b), 44-10-504(2), 44-10-601(4), 44-10-602(4), 44-10-603(6), 44-10-604(1)(b), and 44-10-604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII).Rule was revised to separate and clarify the internal audit requirement and scoring rubric from Rule 4-230(M)(2).MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 4-240(B)Regulated Marijuana Testing Program: Contaminated Product and Failed Test Results and ProceduresRevision44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1)(b), 44-10-504(2), 44-10-601(4), 44-10-602(4), 44-10-603(6), 44-10-604(1)(b), and 44-10-604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII).Rule was revised to remove "flower, wet whole plant, or trim" from the rule.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 4-240(B)(2)(a)Regulated Marijuana Testing Program: Contaminated Product and Failed Test Results and ProceduresRevision44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1)(b), 44-10-504(2), 44-10-601(4), 44-10-602(4), 44-10-603(6), 44-10-604(1)(b), and 44-10-604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII).Rule was revised to add "For Regulated Marijuana flower, trim, fresh frozen and Pre-Rolled Marijuana" as the title of the rule for consistency.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 4-240(C)(3)(c)Regulated Marijuana Testing Program: Contaminated Product and Failed Test Results and ProceduresRevision44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1)(b), 44-10-504(2), 44-10-601(4), 44-10-602(4), 44-10-603(6), 44-10-604(1)(b), and 44-10-604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII).Rule has been revised to add subparagraph (C)(1) to the rule for clarity.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 4-245(D)Regulated Marijuana Testing Program: ExemptionsRepeal44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1)(b), 44-10-504(2), 44-10-601(4), 44-10-602(4), 44-10-603(6), 44-10-604(1)(b), and 44-10-604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII).Rule was repealed.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-115(A)Medical Marijuana Sales: General Limitations or Prohibited ActsRevision44-10-202(1)(c), 44-10-203(1)(k), 44-10-313(7), 44-10-313(4), 44-10-401(2)(a)(I), 44-10-501, and 44-10-505, 44-10-501(10) C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 14(4).Rule was revised to change the total, aggregate ounces of Medical Marijuana from the previous "30 days" to "60 days".MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-115(N)Medical Marijuana Sales: General Limitations or Prohibited ActsNew44-10-202(1)(c), 44-10-203(1)(k), 44-10-313(7), 44-10-313(4), 44-10-401(2)(a)(I), 44-10-501, and 44-10-505, 44-10-501(10) C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 14(4).New rule explicitly prohibiting subletting, subleasing, and independent contractor agreements, and intellectual property agreements.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-205(H)(2)Medical Marijuana Cultivation Facility: License PrivilegesRevision44-10-202(1)(c), 44-10-203(1)(k), 44-10-401(2)(a)(II), 44-10-313, 44-10-502, and 44-10-503, C.R.S.Revised rule language from "addendum" to "application" to match terminology in statute.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-210(A)(2)Medical Marijuana Cultivation Facility: General Limitations or Prohibited ActsNew44-10-201, 44-10-202(1)(c), 44-10-203(1)(k), 44-10-313, 44-10-401(2)(a)(II), 44-10-501, 44-10-502, 44-10-503, and 44-10-505, C.R.S.New rule adding a prohibition against repackaging or altering label information.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-210(F)Medical Marijuana Cultivation Facility: General Limitations or Prohibited ActsNew44-10-201, 44-10-202(1)(c), 44-10-203(1)(k), 44-10-313, 44-10-401(2)(a)(II), 44-10-501, 44-10-502, 44-10-503, and 44-10-505, C.R.S.New rule explicitly prohibiting subletting, subleasing, and independent contractor agreements, and intellectual property agreements.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-310(B)Medical Marijuana Products Manufacturer: General Limitations or Prohibited ActsNew44-10-202(1)(c), 44-10-203(1)(k), 44-10-401(2)(a)(III), and 44-10-503, C.R.S.New rule adding a prohibition against repackaging or altering label information.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-310(F)Medical Marijuana Products Manufacturer: General Limitations or Prohibited ActsRevision44-10-202(1)(c), 44-10-203(1)(k), 44-10-401(2)(a)(III), and 44-10-503, C.R.S.New rule adding a prohibition against repackaging or altering label information.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-310(I)Medical Marijuana Products Manufacturer: General Limitations or Prohibited ActsNew44-10-202(1)(c), 44-10-203(1)(k), 44-10-401(2)(a)(III), and 44-10-503, C.R.S.New rule explicitly prohibiting subletting, subleasing, and independent contractor agreements, and intellectual property agreements.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-320(C)(3)(b)(i)Medical Marijuana Products Manufacturer: R-and-D Unit ProtocolsRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-401(2)(a)(III), and 44-10-503 C.R.S.Rule was revised to reflect the legal possession limit.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-335(B)Medical Marijuana Products Manufacturer: Ability to Change DesignationNew44-10-202(1)(c), 44-10-203(1)(k), 44-10-401(2)(a)(III), and 44-10-503, 44-10-503(12)(a)-(b), and 39-28.8-297, C.R.S.New rule explicitly stating prohibition on transferring Medical Marijuana Concentrate to a Retail Marijuana Concentrate.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-410(L)(2) and 1 CCR 212-3 Rule 6-410(K)(2)Medical Marijuana Testing Facilities: General Limitations or Prohibited Acts Retail Marijuana Testing Facilities: General Limitations or Prohibited ActsRevision44-10-202(1)(c), 44-10-203(2)(h), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f)(II), 44-10-203(2)(f)(IV), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-313(8)(a), 44-10-401(2)(a)(IV), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1), and 44-10-504(2), 44-10-701, and 35-61-105.5, C.R.S. and 44-10-202(1)(a), 44-10-202(1)(b), 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(c), 44-10-203(2)(d), 44-10-202(4), 44-10-203(2)(h), 44-10-203(2)(y), 44-10-203(3)(c), 44-10-203(2)(d), 44-10-401(2)(b)(IV), 44-10-604, 44-10-701, 35-61-104, and 35-61-105.5, C.R.S.Rule was revised to add "or units" and "based on the information on the transport manifest" for additional clarity.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-410(L)(2.5) and 1 CCR 212-3 Rule 6-410(K)(2.5)Medical Marijuana Testing Facilities: General Limitations or Prohibited Acts Retail Marijuana Testing Facilities: General Limitations or Prohibited ActsNew44-10-202(1)(c), 44-10-203(2)(h), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f)(II), 44-10-203(2)(f)(IV), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-313(8)(a), 44-10-401(2)(a)(IV), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1), and 44-10-504(2), 44-10-701, and 35-61-105.5, C.R.S. and 44-10-202(1)(a), 44-10-202(1)(b), 44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(c), 44-10-203(2)(d), 44-10-202(4), 44-10-203(2)(h), 44-10-203(2)(y), 44-10-203(3)(c), 44-10-203(2)(d), 44-10-401(2)(b)(IV), 44-10-604, 44-10-701, 35-61-104, and 35-61-105.5, C.R.S.New rule requiring a Testing Facilities to notify the Division when a Test Batch submission does not contain minimum number of samples to test.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-430(O) and 1 CCR 212-3 Rule 6-430(O)Medical Marijuana Testing Facilities: Analytical Processes Retail Marijuana Testing Facilities: Analytical ProcessesNew44-10-203(2)(d), 44-10-401(2)(a)(IV), and 44-10-504, C.R.S. and 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-202(4), 44-10-401(2)(b)(IV), and 44-10-604, C.R.S.New rule detailing potency testing procedures for Regulated Marijuana Products.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-441(D)(11) and 1 CCR 212-3 Rule 6-441(D)(11)Medical Marijuana Testing Facility: Certificate of Analysis (COA) Retail Marijuana Testing Facilities: Certificate of Analysis (COA)New44-10-203(2)(d), 44-10-401(2)(a)(IV), and 44-10-504, C.R.S. and 44-10-203(2)(d), 44-10-401(2)(a)(IV), and 44-10-604, C.R.S.New rule adding COA requirement to identify Test Batch or package amounts in weight or units.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-605(A) and 1 CCR 212-3 Rule 6-605(A)Medical Marijuana Business Operator: License Privileges Retail Marijuana Business Operator: License PrivilegesRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S. and 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(b)(VI), and 44-10-606, C.R.S.Rule was revised to clarify operator license privileges.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-605(A.5) and 1 CCR 212-3 Rule 6-605(A.5)Medical Marijuana Business Operator: License Privileges Retail Marijuana Business Operator: License PrivilegesNew44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S. and 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(b)(VI), and 44-10-606, C.R.S.New rule to explicitly state an operator license is required.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-605(B) and 1 CCR 212-3 Rule 6-605(B)Medical Marijuana Business Operator: License Privileges Retail Marijuana Business Operator: License PrivilegesRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S. and 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(b)(VI), and 44-10-606, C.R.S.Rule was revised to remove the requirements for an operator to maintain its own place of business.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-605(D)Medical Marijuana Business Operator: License PrivilegesRepeal44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S.Rule was repealed.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-605(E)Medical Marijuana Business Operator: License PrivilegesRepeal44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S.Rule was repealed.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-605(F)Medical Marijuana Business Operator: License PrivilegesRepeal44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S.Rule was repealed.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-605(G) and 1 CCR 212-3 Rule 6-605(G)Medical Marijuana Business Operator: License Privileges Retail Marijuana Business Operator: License PrivilegesNew44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S. and 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(b)(VI), and 44-10-606, C.R.S.New rule adding a list of authorized operator activities.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-610(A)Medical Marijuana Business Operators: General Limitations or Prohibited ActsRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S.Rule was revised to provide for additional clarity.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-610(C)Medical Marijuana Business Operators: General Limitations or Prohibited ActsRepeal44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S.Rule was repealed.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-610(F)(2)(c)Medical Marijuana Business Operators: General Limitations or Prohibited ActsRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S.Rule was revised to provide for additional clarity.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-610(G)Medical Marijuana Business Operators: General Limitations or Prohibited ActsRepeal44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S.Rule was repealed.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-610(H)(1)Medical Marijuana Business Operators: General Limitations or Prohibited ActsRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S.Rule was revised to provide for additional clarity.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-610(H)(2)(a)Medical Marijuana Business Operators: General Limitations or Prohibited ActsRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S.Rule was revised to provide for additional clarity.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-610(H)(3)Medical Marijuana Business Operators: General Limitations or Prohibited ActsRepeal44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S.Rule was repealed.MED Stakeholder ListAdopted09/10/2026
5-610(I)Medical Marijuana Business Operators: General Limitations or Prohibited ActsRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S.Rule was revised to provide for additional clarity.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-610(K) and 1 CCR 212-3 Rule 6-610(K)Medical Marijuana Business Operators: General Limitations or Prohibited Acts Retail Marijuana Business Operators: General Limitations or ProhibitedNew44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S. and 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(b)(VI), and 44-10-606, C.R.S.New rule adding a list of prohibited operator activities.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-615(A)(2) and 1 CCR 212-3 Rule 6-615(A)(2)Medical Marijuana Business Operators: Employee Licenses for Personnel Retail Marijuana Business Operators: Employee Licenses for PersonnelRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S. 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-313(12), 44-10-401(2)(b)(VI), and 44-10-401(2)(c) C.R.S.Revised rule to clarify which operator personnel must hold Employee License.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-615(B) and 1 CCR 212-3 Rule 6-615(B)Medical Marijuana Business Operators: Employee Licenses for Personnel Retail Marijuana Business Operators: Employee Licenses for PersonnelRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S. 44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-313(12), 44-10-401(2)(b)(VI), and 44-10-401(2)(c) C.R.S.Revised rule to clarify when an employee license is not required.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-615(C)Medical Marijuana Business Operators: Employee Licenses for PersonnelRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S.Rule was revised to provide for additional clarity.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-620(A)(1)Medical Marijuana Business Operators: Business Records RequiredRepeal44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S.Rule was repealed.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 5-620(B)Medical Marijuana Business Operators: Business Records RequiredRepeal44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S.Rule was repealed.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-110(Q)Retail Marijuana Sales: General Limitations or Prohibited ActsNew44-10-202(1)(c), 44-10-203(2)(g), 44-10-203(2)(h), 44-10-203(4)(b), 44-10-203(1)(k), 44-10-203(2)(aa) 44-10-401(2)(b)(I), 44-10-401(2)(b)(XI), 44-10-701(1)(a), 44-10-701(3)(d) and (f), 44-10-601 and 44-10-611, C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsections 16(3)(a), 16(5)(a)(V) and 16(5)(a)(VIII).New rule explicitly prohibiting subletting, subleasing, and independent contractor agreements, and intellectual property agreements.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-205(I)(2)Retail Marijuana Cultivation Facility: License PrivilegesRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(h), 44-10-203(2)(j), 44-10-203(2)(r), 44-10-203(3)(c), 44-10-313(14), 44- 10-401(2)(b)(II), and 44-10-602, C.R.S.Revised rule language from "addendum" to "application" to match terminology in statute.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-210(A)(2)Retail Marijuana Cultivation Facility: General Limitations or Prohibited ActsNew44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(f), 44-10-203(2)(h), 44-10-203(2)(j), 44-10-203(2)(aa), 44-10-701(2)(a), 44-10-602, and 44-10-607, C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(V).New rule adding a prohibition against repackaging or altering label information.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-210(F)Retail Marijuana Cultivation Facility: General Limitations or Prohibited ActsNew44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(f), 44-10-203(2)(h), 44-10-203(2)(j), 44-10-203(2)(aa), 44-10-701(2)(a), 44-10-602, and 44-10-607, C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(V).New rule explicitly prohibiting subletting, subleasing, and independent contractor agreements, and intellectual property agreements.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-310(A)Retail Marijuana Products Manufacturer: General Limitations or Prohibited ActsNew44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(f), 44-10-203(2)(g), 44-10-203(2)(h), 44-10-203(2)(i), 44-10-203(2)(y), 44-10-203(2)(aa), 44-10-203(3)(d), 44-10-401(2)(b)(III), 44-10-401(2)(b)(VIII), 44-10-603, 44-10-608, and 44-10-701(2)(a), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(V).New rule adding a prohibition against repackaging or altering label information.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-310(I)Retail Marijuana Products Manufacturer: General Limitations or Prohibited ActsNew44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(f), 44-10-203(2)(g), 44-10-203(2)(h), 44-10-203(2)(i), 44-10-203(2)(y), 44-10-203(2)(aa), 44-10-203(3)(d), 44-10-401(2)(b)(III), 44-10-401(2)(b)(VIII), 44-10-603, 44-10-608, and 44-10-701(2)(a), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(V).New rule explicitly prohibiting subletting, subleasing, and independent contractor agreements, and intellectual property agreements.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-335(B)Retail Marijuana Products Manufacturer: Ability to Change DesignationNew44-10-202(1)(c), 44-10-203(1)(k), 44-10-401(2)(b)(III), 44-10-401(2)(b)(VIII), 44-10-603, 44-10-603(15)(a)-(b), 44-10-608, and 39-28.8-300 C.R.S.New rule explicitly stating prohibition on accepting Medical Marijuana Concentrate to a Retail Marijuana Concentrate.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-605(D)Retail Marijuana Business Operator: License PrivilegesRepeal44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(b)(VI), and 44-10-606, C.R.S.Rule was repealed.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-605(E)Retail Marijuana Business Operator: License PrivilegesRepeal44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(b)(VI), and 44-10-606, C.R.S.Rule was repealed.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-605(F)Retail Marijuana Business Operator: License PrivilegesRepeal44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(b)(VI), and 44-10-606, C.R.S.Rule was repealed.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-610(A)Retail Marijuana Business Operators: General Limitations or Prohibited ActsRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(b)(VI), and 44-10-606, C.R.S.Rule was revised to provide for additional clarity.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-610(C)Retail Marijuana Business Operators: General Limitations or Prohibited ActsRepeal44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(b)(VI), and 44-10-606, C.R.S.Rule was repealed.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-610(F)(2)(c)Retail Marijuana Business Operators: General Limitations or Prohibited ActsRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(b)(VI), and 44-10-606, C.R.S.Rule was revised to provide for additional clarity.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-610(G)Retail Marijuana Business Operators: General Limitations or Prohibited ActsRepeal44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(b)(VI), and 44-10-606, C.R.S.Rule was repealed.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-610(H)(1)Retail Marijuana Business Operators: General Limitations or Prohibited ActsRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(b)(VI), and 44-10-606, C.R.S.Rule was revised to provide for additional clarity.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-610(H)(2)(a)Retail Marijuana Business Operators: General Limitations or Prohibited ActsRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(b)(VI), and 44-10-606, C.R.S.Revised rule for clarity.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-610(H)(3)Retail Marijuana Business Operators: General Limitations or Prohibited ActsRepeal44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(b)(VI), and 44-10-606, C.R.S.Rule was repealed.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-610(I)Retail Marijuana Business Operators: General Limitations or Prohibited ActsRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(b)(VI), and 44-10-606, C.R.S.Rule was revised to provide for additional clarity.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-615(C)Retail Marijuana Business Operators: Employee Licenses for PersonnelRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-313(12), 44-10-401(2)(b)(VI), and 44-10-401(2)(c) C.R.S.Rule was revised to provide for additional clarity.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-620(A)(1)Retail Marijuana Business Operators: Business Records RequiredRepeal44-10-202(1)(c), 44-10-203(1)(c), and 44-10-203(1)(k), C.R.S.Rule was repealed.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 6-620(B)Retail Marijuana Business Operators: Business Records RequiredRepeal44-10-202(1)(c), 44-10-203(1)(c), and 44-10-203(1)(k), C.R.S.Rule was repealed.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 8-110(B)(3)(c)Requirement for Inspections and Investigations, Searches, Administrative Holds, Embargos, Voluntary SurrendersRevision44-10-202(1)(c), 44-10-203(1)(c), 44-10-203(1)(f), 44-10-202(1)(g), 44-10-203(2)(g), 44-10-203(2)(h), 44-10-207, 44-10-203(1)(k), and 44-10-902, C.R.S.Revised rule to extend the administrative hold expiration period from 120 days to 180 days.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 8-235(A)(4)(r)PenaltiesNew44-10-202(1)(c), 44-10-203(1)(k), 44-10-203(2)(l), 44-10-701, and 44-10-901(3)(b), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(IX).New rule for unauthorized Transfers to avoid tax liabilities or harm the public, health, safety or welfare.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 8-235(A)(4)(s)PenaltiesNew44-10-202(1)(c), 44-10-203(1)(k), 44-10-203(2)(l), 44-10-701, and 44-10-901(3)(b), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(IX).New rule for failure to make required biennial license payment.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 8-235(C)(9)(g)PenaltiesNew44-10-202(1)(c), 44-10-203(1)(k), 44-10-203(2)(l), 44-10-701, and 44-10-901(3)(b), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(IX).New rule adding use of a third party to collect samples for required testing as a mitigating factor.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 3-905(B)(13), 1 CCR 212-3 Rule 3-1005(B), 1 CCR 212-3 Rule 3-1005(B)(1)(a), 1 CCR 212-3 Rule 3-1005(B)(1)(c), 1 CCR 212-3 Rule 3-1005(B)(2), 1 CCR 212-3 Rule 3-1025(B), 1 CCR 212-3 Rule 3-1025(B)(1), 1 CCR 212-3 Rule 3-1025(B)(1)(a), 1 CCR 212-3 Rule 3-1025(B)(1)(b), 1 CCR 212-3 Rule 3-1025(B)(2), 1 CCR 212-3 Rule 4-215(B)(1), 1 CCR 212-3 Rule 4-215(C)(1), 1 CCR 212-3 Rule 4-215(E)(2), 1 CCR 212-3 Rule 4-215(E)(4), 1 CCR 212-3 Rule 4-215(E)(5), 1 CCR 212-3 Rule 4-215(G), 1 CCR 212-3 Rule 4-215(H), 1 CCR 212-3 Rule 4-215(H)(1), 1 CCR 212-3 Rule 4-215(I), 1 CCR 212-3 Rule 4-215(J)(3)(a)(i), 1 CCR 212-3 Rule 4-215(J)(3)(a)(xi), 1 CCR 212-3 Rule 4-215(J)(4)(a)(i), 1 CCR 212-3 Rule 4-215(J)(5)(a)(ii), 1 CCR 212-3 Rule 4-215(J)(7)(a)(i), 1 CCR 212-3 Rule 4-215(J)(7)(b)(i), 1 CCR 212-3 Rule 4-215(J)(7)(c)(i), 1 CCR 212-3 Rule 4-215(J)(8)(a)(i), 1 CCR 212-3 Rule 4-230(A), 1 CCR 212-3 Rule 4-230(C), 1 CCR 212-3 Rule 4-230(G), 1 CCR 212-3 Rule 4-230(I), 1 CCR 212-3 Rule 4-230(N), 1 CCR 212-3 Rule 4-230(N)(1), 1 CCR 212-3 Rule 4-230(N)(1)(d), 1 CCR 212-3 Rule 4-230(N)(2), 1 CCR 212-3 Rule 4-230(N)(3), 1 CCR 212-3 Rule 4-230(N)(3)(b), 1 CCR 212-3 Rule 4-230(N)(3)(c), 1 CCR 212-3 Rule 4-230(N)(4), 1 CCR 212-3 Rule 4-240(C)(2)(c)(ii), 1 CCR 212-3 Rule 4-240(C)(2)(c)(ii)(B), 1 CCR 212-3 Rule 4-240(C)(2)(c)(iii)(B), 1 CCR 212-3 Rule 4-240(C)(3)(c)(i), 1 CCR 212-3 Rule 4-240(C)(3)(c)(iii), 1 CCR 212-3 Rule 4-240(C)(3)(c)(iv), 1 CCR 212-3 Rule 4-245(B), 1 CCR 212-3 Rule 4-245(B)(1), 1 CCR 212-3 Rule 4-245(B)(2), 1 CCR 212-3 Rule 5-315(D)(9)(d), 1 CCR 212-3 Rule 5-315(D)(9)h), 1 CCR 212-3 Rule 5-425(A)(24), 1 CCR 212-3 Rule 6-315(D)(9)(d), 1 CCR 212-3 Rule 6-315(D)(9)(h), and 1 CCR 212-3 Rule 6-425(A)(25).Various sections throughout ruleRevision44-10-202(1)(b)-(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(l), 44-10-203(2)(m), and 44-10-901(1), C.R.S.Rule revisions to replace the term "Wet whole plant" with "Fresh frozen" to align with the Tax Division. COMMENTS: Terminology was updated to align with the Tax Division's emergency rules, adopted August 4, 2026.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 3-825(C)(2), 1 CCR 212-3 Rule 4-210(E)(1), 1 CCR 212-3 Rule 4-210(E)(2), 1 CCR 212-3 Rule 4-210(E)(4), 1 CCR 212-3 Rule 4-230(D)(1), 1 CCR 212-3 Rule 4-230(D)(2), 1 CCR 212-3 Rule 4-230(D)(3), 1 CCR 212-3 Rule 4-230(J), 1 CCR 212-3 Rule 4-230(J)(1), and 1 CCR 212-3 Rule 6-310(E).Various sections throughout ruleRevision44-10-202(1)(b)-(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(l), 44-10-203(2)(m), and 44-10-901(1), C.R.S.Rule revisions to replace or remove the term “homogeneity” with “serving uniformity,” as a more precise and descriptive term.MED Stakeholder ListAdopted09/10/2026
1 CCR 212-3 Rule 2-225(A)(1), 1 CCR 212-3 Rule 2-225(D)(1)(d), 1 CCR 212-3 Rule 2-230 - Basis and Purpose, 1 CCR 212-3 2-230(B), 1 CCR 212-3 2-230(D)(2), 1 CCR 212-3 Rule 2-235 - Basis and Purpose, 1 CCR 212-3 Rule 2-240(A), 1 CCR 212-3 Rule 2-255(C.5), 1 CCR 212-3 Rule 2-275(B)(5), 1 CCR 212-3 Rule 3-310(A)(4), 1 CCR 212-3 Rule 3-315 - Basis and Purpose, 1 CCR 212-3 Rule 3-315(B)(3), 1 CCR 212-3 Rule 3-315(B)(6), 1 CCR 212-3 Rule 3-320(B), 1 CCR 212-3 Rule 3-320(B)(1), 1 CCR 212-3 Rule 3-320(B)(1)(a), 1 CCR 212-3 Rule 3-320(B)(1)(b), 1 CCR 212-3 Rule 3-320(B)(2), 1 CCR 212-3 Rule 3-320(B)(3), 1 CCR 212-3 Rule 3-320(B)(5), 1 CCR 212-3 Rule 3-325 - Basis and Purpose, 1 CCR 212-3 Rule 3-330 - Basis and Purpose, 1 CCR 212-3 Rule 3-330(A), 1 CCR 212-3 Rule 3-330(B), 1 CCR 212-3 Rule 3-330(D)(4), 1 CCR 212-3 Rule 3-335 - Basis and Purpose, 1 CCR 212-3 Rule 3-335(D)(4)(d)(i), 1 CCR 212-3 Rule 3-335(D)(4)(e)(i), 1 CCR 212-3 Rule 3-335(D)(4)(e)(ii), 1 CCR 212-3 Rule 3-335(G.5), 1 CCR 212-3 Rule 3-335(M)(2), 1 CCR 212-3 Rule 3-336(C)(1), 1 CCR 212-3 Rule 3-336(D)(4)(b)(ii), 1 CCR 212-3 Rule 3-336(D)(4)(c)(i)(C), 1 CCR 212-3 Rule 3-405(C)(5), 1 CCR 212-3 Rule 3-520(A), 1 CCR 212-3 Rule 3-520(H)(8), 1 CCR 212-3 Rule 3-605(B)(1), 1 CCR 212-3 Rule 3-605(B)(2)(c), 1 CCR 212-3 Rule 3-605(G)(1), 1 CCR 212-3 Rule 3-605(G)(3), 1 CCR 212-3 Rule 3-605(G)(3)(b), 1 CCR 212-3 Rule 3-605(H)(1)(b)(iv), 1 CCR 212-3 Rule 3-605(H)(3)(h), 1 CCR 212-3 Rule 3-605(I)(1)(a), 1 CCR 212-3 Rule 3-605(I)(2)(a), 1 CCR 212-3 Rule 3-615(D), 1 CCR 212-3 Rule 3-615(E)(1), 1 CCR 212-3 Rule 3-615(E)(8), 1 CCR 212-3 Rule 3-615(F)(1), 1 CCR 212-3 Rule 3-805(E)(3)a), 1 CCR 212-3 Rule 3-905(A)(2)(a), 1 CCR 212-3 Rule 3-905(A)(2)(b), 1 CCR 212-3 Rule 3-905(B.5)(6), 1 CCR 212-3 3-1005(B)(2)(a), 1 CCR 212-3 Rule 3-1005(E)(2)(f), 1 CCR 212-3 Rule 3-1005(F), 1 CCR 212-3 Rule 3-1010(C), 1 CCR 212-3 Rule 3-1010(C)(3)(a)(i), 1 CCR 212-3 Rule 3-1010(D)(1)(d - e), 1 CCR 212-3 Rule 3-1010(E), 1 CCR 212-3 Rule 3-1015(B)(2)(a), 1 CCR 212-3 Rule 3-1015(B)(2)(b), 1 CCR 212-3 Rule 3-1015(B)(3)(c)(i), 1 CCR 212-3 Rule 3-1025(D)(2), 1 CCR 212-3 Rule 3-1105 - Basis and Purpose, 1 CCR 212-3 Rule 3-1110(A), 1 CCR 212-3 Rule 4-205(F)(1), 1 CCR 212-3 Rule 4-210(C)(3), 1 CCR 212-3 Rule 4-215(B)(2), 1 CCR 212-3 Rule 4-215(J), 1 CCR 212-3 Rule 4-215(J)(3)(b), 1 CCR 212-3 Rule 4-215(J)(6)(a)(i), 1 CCR 212-3 Rule 4-220(A)(1), 1 CCR 212-3 Rule 4-220(A)(1)(b), 1 CCR 212-3 Rule 4-220(A)(2)(a), 1 CCR 212-3 Rule 4-220(A)(2)(a), 1 CCR 212-3 Rule 4-220(A)(2)(b), 1 CCR 212-3 Rule 4-220(A)(2)(b)(ii), 1 CCR 212-3 Rule 4-220(A)(2)(b)(iii), 1 CCR 212-3 Rule 4-225(B), 1 CCR 212-3 Rule 4-225(D)(1), 1 CCR 212-3 Rule 4-225(D)(2)(c), 1 CCR 212-3 Rule 4-225(F)(3)(a), 1 CCR 212-3 Rule 4-230(K)(1)(g), 1 CCR 212-3 Rule 4-230(M)(3), 1 CCR 212-3 Rule 4-240(C)(3)(c)(iv)(D), 1 CCR 212-3 Rule 4-240(C)(3)(c)(iv)(E), 1 CCR 212-3 Rule 4-245(E), 1 CCR 212-3 Rule 5-105(J)(1 - 6), 1 CCR 212-3 Rule 5-115(C), 1 CCR 212-3 Rule 5-125(A)(1)(c), 1 CCR 212-3 Rule 5-125(A)(3)(a)(iii)(B), 1 CCR 212-3 Rule 5-125(C)(1), 1 CCR 212-3 Rule 5-210(D), 1 CCR 212-3 Rule 5-225(D)(1), 1 CCR 212-3 Rule 5-225(E)(2)(d)(i)(C), 1 CCR 212-3 Rule 5-230(B), 1 CCR 212-3 Rule 5-230(C)(4), 1 CCR 212-3 Rule 5-305(G), 1 CCR 212-3 Rule 5-315(D)(9), 1 CCR 212-3 Rule 5-420(A)(1), 1 CCR 212-3 Rule 5-441(D)(9), 1 CCR 212-3 Rule 5-441(D)(10), 1 CCR 212-3 Rule 5-720(J)(2), 1 CCR 212-3 Rule 6-105(A), 1 CCR 212-3 Rule 6-105(B.5), 1 CCR 212-3 Rule 6-105(I)(1 - 6), 1 CCR 212-3 Rule 6-441(D)(9), 1 CCR 212-3 Rule 6-441(D)(10), 1 CCR 212-3 Rule 8-110(B)(1)(a), 1 CCR 212-3 Rule 8-205(A)(1), 1 CCR 212-3 Rule 8-235(A)(4)(p), 1 CCR 212-3 Rule 8-235(B), and 1 CCR 212-3 Rule 8-235(C)(9)(h).Various sections throughout ruleRevision44-10-202(1)(b)-(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(l), 44-10-203(2)(m), and 44-10-901(1), C.R.S.Rule revisions were made throughout the rule to correct syntax and punctuation corrections.MED Stakeholder ListAdopted09/10/2026